T. Lapperre (København NV, Denmark), F. Luppi (Modena, Italy), M. Barrecheguren Fernandez (Barcelona, Spain), M. Vukoja (Sremska Kamenica, Republic of Serbia)
A cross-sectional study in severe COPD patients in the Middle East and Africa (MEA): Symptoms variability and quality of life
N. Kokturk (Ankara, Turkey), M. Soliman (Cairo, Egypt), A. Albanna (Jeddah, Saudi Arabia), R. Van Zyl Smit (Cape Town, South Africa), E. Malvolti (Luton, United Kingdom), D. Ahmed (Cairo, Egypt)
|  |
A cross-sectional study in severe COPD patients in the Middle East and Africa (MEA): Methodology and patients’ profile
A. Ashraf (Abu Dhabi, United Arab Emirates), H. Gunen (Istanbul, Turkey), A. Gurgun (Izmir, Turkey), N. Zidouni (Alger, Algeria), M. Khadadah (Jabriya, Kuwait), W. Abuharbid (Dubai, United Arab Emirates)
| |
Evaluation of Slow Vital capacity and Forced Vital Capacity in patients with COPD
O. Nesterovska (Chernivtsi, Ukraine), G. Stupnytska (Chernivtsi, Ukraine), A. Stupnytska (Chernivtsi, Ukraine)
| |
Diagnosis of COPD in patients with multidrug-resistant tuberculosis
H. Baradzina (Minsk, Belarus)
| |
Adherence to GOLD guidelines practices in the management of COPD in Tunisia
A. Sana (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), G. Imen (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), G. Abdelhamid (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia), B. Mohamed (Sousse, Tunisia)
|  |
Disease specific knowledge in Tunisian COPD patients
R. Kaddoussi (sousse, Tunisia), h. rejeb (Sousse, Tunisia), I. Ben Saida (sousse, Tunisia), S. Jdidi (sousse, Tunisia), M. Ben Khelifa (sousse, Tunisia), W. Benzarti (sousse, Tunisia), S. Aissa (sousse, Tunisia), I. Gargouri (sousse, Tunisia), A. Abdelghani (sousse, Tunisia), A. Garrouche (sousse, Tunisia), A. Hayouni (sousse, Tunisia), M. Benzarti (sousse, Tunisia)
| |
Evaluation of the demographics, diagnosis and monitoring, management, device usage and adherence among COPD patients: A survey of doctors in Nepal
R. Chokhani (Kathmandu, Nepal), N. Bhatta (Kathmandu, Nepal), A. Mukhopadhyay (Mumbai, India), V. Gaur (Mumbai, India), J. Gogtay (Mumbai, India)
| |
Characterization of patients with severe COPD
R. Malo De Molina Ruiz (Madrid , Spain), C. Esquinas (Barcelona, Spain), C. Martinez Rivera (Barcelona, Spain), E. Marquez Martin (Sevilla, Spain), E. Naval Sendra (Valencia , Spain), M. Valle Falcones (Madrid , Spain), E. Cabrera Cesar (Malaga, Spain), A. Boldova Loscertales (Zaragoza , Spain), J. Callejas (Albacete, Spain), M. Miravitlles (Barcelona, Spain)
| |
The distribution of COPD in general practice using three different GOLD classification
I. Salakhova (Kazan, Russian Federation), A. Vizel (Kazan, Russian Federation), A. Vafina (Kazan, Russian Federation), I. Vizel (Kazan, Russian Federation)
| |
Opportunistic screening for COPD in primary care - A pooled analysis of 6.710 symptomaticsmokers and ex-smokers
A. Katsimigas (Hvidovre, Denmark), O. Tupper (Hvidovre, Denmark), P. Kjeldgaard (Hvidovre, Denmark), C. Ulrik (Hvidovre, Denmark)
| |
Determinants of dyspnea in COPD patients: the French PALOMB cohort
. Ouaalaya (Bordeaux, France), E. Berteaud (Bordeaux, France), A. Bernardy (Bayonne, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), L. Falque (Bordeaux, France), F. Le Guillou (La Rochelle, France), C. Nocent-Ejnaini (Bayonne, France), L. Nguyen (Bordeaux, France), . Ozier (Bordeaux, France), . Casteigt (Bordeaux, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France)
| |
Prevalence of COPD in heroin smokers attending treatment centres assessed using LLN and relationship to drug consumption
H. Burhan (Liverpool, United Kingdom), R. Young (Liverpool, United Kingdom), T. Byrne (Liverpool, United Kingdom), R. Peat (Liverpool, United Kingdom), J. Furlong (Liverpool, United Kingdom), S. Renwick (Liverpool, United Kingdom), T. Elkin (Liverpool, United Kingdom), S. Oelbaum (Liverpool, United Kingdom), P. Walker (Liverpool, United Kingdom)
| |
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF THE CANCER OF PULMON WITH COPD IN OUR HEALTH AREA IN THE YEARS 2016-2017
A. Vílchez Parras (Jaén, Spain), M. López López (Jaén, Spain), G. Pérez Chica (Jaén, Spain), C. Lacárcel Bautista (Jaén, Spain)
| |
COPD in elderly patients – an analysis of the DACCORD observational study
H. Worth (Fuerth, Germany), R. Buhl (Mainz, Germany), C. Criee (Bovenden, Germany), P. Kardos (Frankfurt, Germany), N. Lossi (Nuernberg, Germany), C. Vogelmeier (Marburg, Germany)
| |
Relation between gender and survival among real-life COPD patients
N. Roche (Paris, France), M. Zysman (Créteil, France), I. Court-Fortune (St Etienne, France), G. Brinchault-Rabin (Rennes, France), P. Nesme-Meyer (Lyon, France), P. Surpas (Charnay, France), G. Deslée (Reims, France), T. Perez (Lille, France), R. Escamilla (Toulouse, France), G. Jebrak (Paris, France), P. Chanez (Marseille, France), J. Paillasseur (Paris, France), D. Caillaud (Clermont-Ferrand, France), P. Burgel (Paris, France)
| |
Non-smoking COPD: an overlooked systemic disease, modifiable by physical activity based on studying a cohort of 386,304 subjects
C. Shu (Taipei, Taiwan), T. Su (Taipei, Taiwan), J. Lee (Miaoli, Taiwan), M. Tsai (Miaoli, Taiwan), C. Wen (Miaoli, Taiwan)
| |
Characteristics of "frequent exacerbators" in mild to moderate COPD patients.
H. Choi (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea)
| |
Bacterial structure of sputum from patients with exacerbations of COPD in a single medical center in Central Kazakhstan
N. Bisenova (Astana, Kazakhstan), A. Yergaliyeva (Astana, Kazakhstan)
| |
Should we be doing more to address cardiovascular risk in patients who have COPD? Learning from a quality improvement project at Basildon Hospital.
O. Atkins (Essex, United Kingdom), M. Pittman (Essex, United Kingdom)
| |